Welcome to Your Personalized N1o1 Assessment
Thank you for participating in this personalized experience. Your responses will not only help determine your current nitric oxide status with an accuracy comparable to test strips, but they will also help Dr. Nathan Bryan develop even more personalized protocols in the future.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
By purchasing N1O1 products, the buyer agrees that the products are for personal use or use by the purchaser only and may not be resold, redistributed, or exported. Unauthorized resale or distribution may lead to legal action, including but not limited to injunctions, seizure of products, and damages. N1O1 enforces its rights against unauthorized resale activities vigorously and will take legal action to protect its intellectual property to the fullest extent of the law.
All company brand names and logos of N1O1 & Pneuma Nitric Oxide LLC are trademarks or registered trademarks of Pneuma Nitric Oxide LLC or its affiliates. Unauthorized use is strictly prohibited.
Investors
Financials, earnings updates, and more.
At Bryan Therapeutics, we are committed to transforming healthcare through groundbreaking nitric oxide-based therapies. Our goal is to improve the quality of life for patients worldwide while delivering long-term value to our stakeholders.
As an investor, you’ll have access to the latest insights about our financial performance, growth strategy, and innovative research initiatives.
Why Invest in Bryan Therapeutics?
Pioneering Science: We are at the forefront of nitric oxide-based treatments for cardiovascular, neurological, and chronic conditions.
Experienced Leadership: Led by Dr. Nathan Bryan, a globally recognized expert in nitric oxide research, we are guided by a team of seasoned professionals.
Promising Pipeline: Our portfolio includes therapies targeting high-impact diseases with significant unmet needs.
Strategic Growth: Recent acquisitions and partnerships have strengthened our capabilities and accelerated drug development programs.
Events
Presentations
Press Releases
SEC Filings & Other
Bryan Therapeutics Inc.,
2407 South Congress Ave E134, Austin, TX 78704